COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,931 Articles (22,057 medRxiv, 7,874 bioRxiv)

Most recent first Previous |  Page 242: Articles 2411-2420  | Next

Tetherin restricts SARS-CoV-2 replication despite antagonistic effects of Spike and ORF7a
Hagelauer, E., Lotke, R., Kmiec, D., Hu, D., Hohner, M., Stopper, S., Layer, M., Nchioua, R., Kirchhoff, F., Sauter, D., Schindler, M.
10.1101/2023.07.28.550997 — Posted: 2023-08-03
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency
Li, Y., Choudhary, M. C., Regan, J., Boucau, J., Nathan, A., Speidel, T., Liew, M. Y., Edelstein, G. E., Kawano, Y., Uddin, R., Deo, R., Marino, C., Getz, M. A., Reynold, Z., Barry, M., Gilbert, R. F., Tien, D., Sagar, S., Vyas, T. D., Flynn, J. P., Hammond, S. P., Novack, L. A., Choi, B., Cernadas, M., Wallace, Z. S., Sparks, J. A., Vyas, J. M., Seaman, M. S., Gaiha, G. D., Siedner, M. J., Barczak, A. K., Lemieux, J. E., Li, J. Z.
10.1101/2023.07.31.23293441 — Posted: 2023-08-02
Frequency of Atypical Pulmonary Manifestations of COVID-19 Patients on Chest CTscan: A cross-sectional study
Borji, S., Isavand, P., Azami, M., Ghafouri, E.
10.1101/2023.07.28.23293261 — Posted: 2023-08-02
Lower Urinary Tract Symptoms in a prospective cohort of COVID-19 survivors
Gomes, C. M., Hisano, M., Souza, J. D., Henriques, J. V. T., De Bessa, J., Moromizato, J., Bosi, T., Mazoni, R., Gismondi, J., Camargo, B., Sammour, Z. M., Bruschini, H., Battistella, L. R., Nahas, W. C.
10.1101/2023.08.01.23293500 — Posted: 2023-08-02
Loss of severe respiratory syncytial virus infection-associated antibody function during the peak of the COVID-19 pandemic mitigation measures
Abu-Raya, B., Reicherz, F., Michalski, C., Majdoub, A., Golding, L., Vienta, M., Granoski, M., Stojic, A., Marchant, D., Lavoie, P. M.
10.1101/2023.07.30.23292881 — Posted: 2023-08-02
Prevalence of long-term symptoms varies by using different post-COVID-19 definitions in positively and negatively tested adults: the PRIME post-COVID study
Pagen, D. M., van Bilsen, C. J., Brinkhues, S., Van Herck, M., Konings, K., den Heijer, C. D., ter Waarbeek, H. L., Spruit, M. A., Hoebe, C. J., Dukers-Muijrers, N. H.
10.1101/2023.07.27.23293244 — Posted: 2023-08-02
Health inequalities in SARS-CoV-2 infection during the second wave in England: REACT-1 study
Wang, H., Ainslie, K. E. C., Eales, O., Walters, C. E., Haw, D., Atchinson, C., Fronterre, C., Diggle, P. J., Ashby, D., Cooke, G., Barclay, W., Ward, H., Darzi, A., Donnelly, C. A., Elliott, P., Riley, S.
10.1101/2023.08.01.23293491 — Posted: 2023-08-02
Recommended distances for physical distancing during COVID-19 pandemics reveal cultural connections between countries
Chai, D., El Mossadeq, L., Raymond, M., Orgogozo, V.
10.1101/2023.08.01.23293497 — Posted: 2023-08-02
The Human Microglia Atlas (HuMicA) Unravels Changes in Homeostatic and Disease-Associated Microglia Subsets across Neurodegenerative Conditions
Martins-Ferreira, R., Calafell-Segura, J., Leal, B., Rodriguez-Ubreva, J., Mereu, E., Pinho e Costa, P., Ballestar, E.
10.1101/2023.08.01.550767 — Posted: 2023-08-02
Growth media affects susceptibility of air-lifted human nasal epithelial cell cultures to SARS-CoV2, but not Influenza A, virus infection.
Resnick, J. D., Wilson, J. L., Anaya, E. U., Conte, A., Li, M., Zhong, W., Beer, M., Pekosz, A.
10.1101/2023.07.31.551381 — Posted: 2023-08-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).